UnitedHealth Group Optumrx — Acquisitions remained flat by 0.0% to $576.25M in Q4 2024 compared to the prior quarter.
Higher spending indicates an aggressive growth strategy, while lower spending suggests a focus on organic growth or capital preservation.
The total cash outflow dedicated to the purchase of businesses or strategic assets specifically within the pharmacy bene...
Comparable to 'Cash paid for acquisitions' found in the investing activities section of the cash flow statement, often broken down by segment.
unh_segment_optum_rx_acquisitions| FY'21 | FY'22 | FY'23 | FY'24 | |
|---|---|---|---|---|
| Value | $0.00 | $3.91B | $0.00 | $2.31B |
| YoY Change | — | — | -100.0% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.